InMode (INMD) Net Income towards Common Stockholders (2018 - 2026)

InMode (INMD) posted quarterly Net Income towards Common Stockholders of $11.6 million for Q1 2026, down 36.48% year-on-year from $18.2 million in Q1 2025, and down 67.49% on a QoQ basis from $35.6 million in Q4 2025.

InMode (INMD) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends

InMode (INMD) has reported Net Income towards Common Stockholders for 9 consecutive years, with $11.6 million the latest figure, recorded in Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 36.48% year-over-year to $11.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $95.7 million (up 28.22% YoY) and the FY2025 annual result came in at $126.8 million, up 20.03% from the prior year.
  • Net Income towards Common Stockholders declined to $11.6 million in Q1 2026 per INMD's latest filing, from $35.6 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for INMD reached as high as $65.2 million in Q4 2023 and fell as low as -$18.4 million in Q4 2024.
  • A 5-year average of $33.1 million and a median of $35.6 million in 2025 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders sank 128.16% — and 2025, when it soared 293.77%.
  • Year by year, Net Income towards Common Stockholders stood at $37.7 million in 2022, then jumped by 72.81% to $65.2 million in 2023, then sank by 128.16% to -$18.4 million in 2024, then surged by 293.77% to $35.6 million in 2025, then sank by 67.49% to $11.6 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $11.6 million, $35.6 million, and $21.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 183.58 Bn 176.28 Bn 6.27 Bn 1.08 Bn
2 Stryker 129.01 Bn 126.13 Bn 3.81 Bn 745.00 Mn
3 Medtronic 108.52 Bn 99.30 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 68.67 Bn 67.22 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.33 Bn 44.66 Bn 1.29 Bn -
6 Dexcom 28.34 Bn 27.23 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 28.07 Bn 25.79 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.89 Bn 26.31 Bn - -
9 Koninklijke Philips 24.12 Bn 21.00 Bn 2.07 Bn 176.78 Mn
10 InMode 978,277.45 -479.15 Mn 61.55 Mn 11.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.56 Mn
Dec 31, 2025 35.56 Mn
Sep 30, 2025 21.86 Mn
Jun 30, 2025 26.74 Mn
Mar 31, 2025 18.20 Mn
Dec 31, 2024 -18.35 Mn
Sep 30, 2024 50.99 Mn
Jun 30, 2024 23.82 Mn
Mar 31, 2024 23.70 Mn
Dec 31, 2023 65.16 Mn
Sep 30, 2023 46.52 Mn
Jun 30, 2023 55.73 Mn
Mar 31, 2023 40.51 Mn
Dec 31, 2022 37.71 Mn
Sep 30, 2022 48.79 Mn
Jun 30, 2022 44.05 Mn
Mar 31, 2022 30.98 Mn
Dec 31, 2021 52.69 Mn
Sep 30, 2021 44.72 Mn
Jun 30, 2021 40.93 Mn